Antibody diluent composition, antibody diluent and preparation method of antibody diluent
The invention firstly provides an antibody diluent composition. The antibody diluent composition is prepared from the components of polyvinyl pyrrolidone and magnesium adenosine triphosphate. Secondly, the invention provides an antibody diluent and a preparation method thereof. The antibody diluent...
Gespeichert in:
Hauptverfasser: | , , , , , , |
---|---|
Format: | Patent |
Sprache: | chi ; eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | CHEN YONG WANG XIAOYA YANG QINGHAI JIANG NINGCHENG ZHOU HONGHUI GAO HUIRAN CHEN HUILING |
description | The invention firstly provides an antibody diluent composition. The antibody diluent composition is prepared from the components of polyvinyl pyrrolidone and magnesium adenosine triphosphate. Secondly, the invention provides an antibody diluent and a preparation method thereof. The antibody diluent is prepared from the components in parts by weight: 0.1-0.2 part of sodium dihydrogen phosphate, 3-3.2 parts of sodium hydrogen phosphate, 8.9-9.1 parts of sodium chloride, 9.5-10.5 parts of bovine serium albumin, 0.8-1.2 parts of Proclin 300, 0.9-1.1 parts of the Polyvinyl pyrrolidone, 0.4-0.6 partof the magnesium adenosine triphosphate, and 950-1050 parts of deionized water. According to the technical scheme, the polyvinyl pyrrolidone and the magnesium adenosine triphosphate are adopted as the components of the antibody diluent; and after the antibody diluent contains the combination of the polyvinyl pyrrolidone and the magnesium adenosine triphosphate, the non-specificity background staining of a polyclonal anti |
format | Patent |
fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CN109991408A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CN109991408A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CN109991408A3</originalsourceid><addsrcrecordid>eNrjZIh0zCvJTMpPqVRIycwpTc0rUUjOzy3IL84syczP01FIRJdNzEtRKChKLUgsSgSpUMhNLcnIT1HIT8NQysPAmpaYU5zKC6W5GRTdXEOcPXRTC_LjU4sLEpNT81JL4p39DA0sLS0NTQwsHI2JUQMAQ1Y7bQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Antibody diluent composition, antibody diluent and preparation method of antibody diluent</title><source>esp@cenet</source><creator>CHEN YONG ; WANG XIAOYA ; YANG QINGHAI ; JIANG NINGCHENG ; ZHOU HONGHUI ; GAO HUIRAN ; CHEN HUILING</creator><creatorcontrib>CHEN YONG ; WANG XIAOYA ; YANG QINGHAI ; JIANG NINGCHENG ; ZHOU HONGHUI ; GAO HUIRAN ; CHEN HUILING</creatorcontrib><description>The invention firstly provides an antibody diluent composition. The antibody diluent composition is prepared from the components of polyvinyl pyrrolidone and magnesium adenosine triphosphate. Secondly, the invention provides an antibody diluent and a preparation method thereof. The antibody diluent is prepared from the components in parts by weight: 0.1-0.2 part of sodium dihydrogen phosphate, 3-3.2 parts of sodium hydrogen phosphate, 8.9-9.1 parts of sodium chloride, 9.5-10.5 parts of bovine serium albumin, 0.8-1.2 parts of Proclin 300, 0.9-1.1 parts of the Polyvinyl pyrrolidone, 0.4-0.6 partof the magnesium adenosine triphosphate, and 950-1050 parts of deionized water. According to the technical scheme, the polyvinyl pyrrolidone and the magnesium adenosine triphosphate are adopted as the components of the antibody diluent; and after the antibody diluent contains the combination of the polyvinyl pyrrolidone and the magnesium adenosine triphosphate, the non-specificity background staining of a polyclonal anti</description><language>chi ; eng</language><subject>INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES ; MEASURING ; PHYSICS ; TESTING</subject><creationdate>2019</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20190709&DB=EPODOC&CC=CN&NR=109991408A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76290</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20190709&DB=EPODOC&CC=CN&NR=109991408A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>CHEN YONG</creatorcontrib><creatorcontrib>WANG XIAOYA</creatorcontrib><creatorcontrib>YANG QINGHAI</creatorcontrib><creatorcontrib>JIANG NINGCHENG</creatorcontrib><creatorcontrib>ZHOU HONGHUI</creatorcontrib><creatorcontrib>GAO HUIRAN</creatorcontrib><creatorcontrib>CHEN HUILING</creatorcontrib><title>Antibody diluent composition, antibody diluent and preparation method of antibody diluent</title><description>The invention firstly provides an antibody diluent composition. The antibody diluent composition is prepared from the components of polyvinyl pyrrolidone and magnesium adenosine triphosphate. Secondly, the invention provides an antibody diluent and a preparation method thereof. The antibody diluent is prepared from the components in parts by weight: 0.1-0.2 part of sodium dihydrogen phosphate, 3-3.2 parts of sodium hydrogen phosphate, 8.9-9.1 parts of sodium chloride, 9.5-10.5 parts of bovine serium albumin, 0.8-1.2 parts of Proclin 300, 0.9-1.1 parts of the Polyvinyl pyrrolidone, 0.4-0.6 partof the magnesium adenosine triphosphate, and 950-1050 parts of deionized water. According to the technical scheme, the polyvinyl pyrrolidone and the magnesium adenosine triphosphate are adopted as the components of the antibody diluent; and after the antibody diluent contains the combination of the polyvinyl pyrrolidone and the magnesium adenosine triphosphate, the non-specificity background staining of a polyclonal anti</description><subject>INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES</subject><subject>MEASURING</subject><subject>PHYSICS</subject><subject>TESTING</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2019</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZIh0zCvJTMpPqVRIycwpTc0rUUjOzy3IL84syczP01FIRJdNzEtRKChKLUgsSgSpUMhNLcnIT1HIT8NQysPAmpaYU5zKC6W5GRTdXEOcPXRTC_LjU4sLEpNT81JL4p39DA0sLS0NTQwsHI2JUQMAQ1Y7bQ</recordid><startdate>20190709</startdate><enddate>20190709</enddate><creator>CHEN YONG</creator><creator>WANG XIAOYA</creator><creator>YANG QINGHAI</creator><creator>JIANG NINGCHENG</creator><creator>ZHOU HONGHUI</creator><creator>GAO HUIRAN</creator><creator>CHEN HUILING</creator><scope>EVB</scope></search><sort><creationdate>20190709</creationdate><title>Antibody diluent composition, antibody diluent and preparation method of antibody diluent</title><author>CHEN YONG ; WANG XIAOYA ; YANG QINGHAI ; JIANG NINGCHENG ; ZHOU HONGHUI ; GAO HUIRAN ; CHEN HUILING</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CN109991408A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>chi ; eng</language><creationdate>2019</creationdate><topic>INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES</topic><topic>MEASURING</topic><topic>PHYSICS</topic><topic>TESTING</topic><toplevel>online_resources</toplevel><creatorcontrib>CHEN YONG</creatorcontrib><creatorcontrib>WANG XIAOYA</creatorcontrib><creatorcontrib>YANG QINGHAI</creatorcontrib><creatorcontrib>JIANG NINGCHENG</creatorcontrib><creatorcontrib>ZHOU HONGHUI</creatorcontrib><creatorcontrib>GAO HUIRAN</creatorcontrib><creatorcontrib>CHEN HUILING</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>CHEN YONG</au><au>WANG XIAOYA</au><au>YANG QINGHAI</au><au>JIANG NINGCHENG</au><au>ZHOU HONGHUI</au><au>GAO HUIRAN</au><au>CHEN HUILING</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Antibody diluent composition, antibody diluent and preparation method of antibody diluent</title><date>2019-07-09</date><risdate>2019</risdate><abstract>The invention firstly provides an antibody diluent composition. The antibody diluent composition is prepared from the components of polyvinyl pyrrolidone and magnesium adenosine triphosphate. Secondly, the invention provides an antibody diluent and a preparation method thereof. The antibody diluent is prepared from the components in parts by weight: 0.1-0.2 part of sodium dihydrogen phosphate, 3-3.2 parts of sodium hydrogen phosphate, 8.9-9.1 parts of sodium chloride, 9.5-10.5 parts of bovine serium albumin, 0.8-1.2 parts of Proclin 300, 0.9-1.1 parts of the Polyvinyl pyrrolidone, 0.4-0.6 partof the magnesium adenosine triphosphate, and 950-1050 parts of deionized water. According to the technical scheme, the polyvinyl pyrrolidone and the magnesium adenosine triphosphate are adopted as the components of the antibody diluent; and after the antibody diluent contains the combination of the polyvinyl pyrrolidone and the magnesium adenosine triphosphate, the non-specificity background staining of a polyclonal anti</abstract><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | chi ; eng |
recordid | cdi_epo_espacenet_CN109991408A |
source | esp@cenet |
subjects | INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES MEASURING PHYSICS TESTING |
title | Antibody diluent composition, antibody diluent and preparation method of antibody diluent |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-29T13%3A40%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=CHEN%20YONG&rft.date=2019-07-09&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECN109991408A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |